RNA, 7SL, cytoplasmic 760, pseudogene (RN7SL760P)

**RNA, 7SL, cytoplasmic 760, pseudogene (RN7SL760P)** is classified as a pseudogene derived from 7SL RNA, which encodes a core component of the signal recognition particle (SRP) responsible for directing newly synthesized proteins to specific locations in the cell[1][5][6]. However, **RN7SL760P itself is a non-functional pseudogene**, meaning it does not produce any active RNA or protein product and lacks known biological function, clinical disease association, or drug interactions[1][5]. The majority of 7SL-derived sequences in the human genome are pseudogenes, largely generated through retrotransposition or other recombination events, with no evidence for direct involvement in cellular signaling or disease[3][5]. As such, it is *not* recognized as a druggable target, receptor, enzyme, nor does it hold therapeutic or biomarker relevance. **Clarifying accuracy:** RN7SL760P, as a pseudogene, is **not** considered a therapeutic target or functional biological molecule; requests related to it as a receptor or drug target are based on a misconception[1][5][3].

Other names

RN7SL760P